Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Neda Al Rawashdh
Institution:
IQVIA (United States)
Observed institution:
IQVIA (United States)
ORCID:
0009-0009-6840-3360
Observed ORCID:
0009-0009-6840-3360
OpenAlex ID:
A5011900688
Overall Survival in Patients With Multiple Myeloma in the U.S.: A Systematic Literature Review of Racial Disparities
2023
·
Joseph Mikhael
, Allie Cichewicz
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
11
PDF
Cost-Effectiveness of Point-of-Care Hepatitis C Virus RNA Testing in the US
2026
·
Neda Al Rawashdh
, Cheryl P. Ferrufino
, et al.
·
JAMA Network Open
·
2
PDF
A Clinical and Economic Comparison of Cell-Based Versus Recombinant Influenza Vaccines in Adults 18–64 Years in the United States
2024
·
Myron J. Levin
, Neda Al Rawashdh
, et al.
·
Vaccines
·
2
PDF
Cost‐Effectiveness of Control‐ IQ + Technology in Insulin‐Treated Patients With Type 2 Diabetes in the United States
2026
·
Neda Al Rawashdh
, Bimal V. Patel
, et al.
·
Diabetes Obesity and Metabolism
Author response for "Cost-Effectiveness of Control-IQ+ Technology in Insulin-Treated Patients with Type 2 Diabetes in the United States"
2026
·
Neda Al Rawashdh
, Bimal V. Patel
, et al.
P-28. A Clinical and Economic Comparison of Non-Egg Influenza Vaccines in Adults 18-64 Years in the U.S
2025
·
Myron J Levin
, Neda Al Rawashdh
, et al.
·
Open Forum Infectious Diseases
PDF
Budget Impact Analysis for Empagliflozin in Patients with Nondiabetic CKD
2024
·
Satabdi Chatterjee
, Neda Al Rawashdh
, et al.
·
Journal of the American Society of Nephrology
Cost-Effectiveness of Empagliflozin in CKD in a Real-World US Population
2024
·
Satabdi Chatterjee
, Neda Al Rawashdh
, et al.
·
Journal of the American Society of Nephrology
Studies on Survival, Effectiveness, and Cost Outcomes of First Line Treatments in Chronic Lymphocytic Leukemia
2021
·
Neda Al Rawashdh
·
UA Campus Repository (The University of Arizona)
Cost-Effectiveness and Value of Perfect Information Analyses for Bruton's Tyrosine Kinase Inhibitors for Patients with Relapsed or Refractory Mantle Cell Lymphoma in the United States
2020
·
Neda Al Rawashdh
·
UA Campus Repository (The University of Arizona)
PDF
Show more works
View as search
Works count:
11
Citation count:
15
H-index:
2
I10-index:
1
Year
Topic
Type